Nanion Corporate Blog


10.05.2021: Research Ins]i[ghts Cardiac Safety Symposium 2021 - Session 1

Session 1 - Challenges in Safety Pharmacology (the first of four sessions across our two-day event)

Selected Publications:

2021 - Applying the CiPA Approach to Evaluate Cardiac Proarrhythmia Risk of some Antimalarials Used Off‐label in the First Wave of COVID‐19

2021 - Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective

Introduction: Niels Fertig & Sonja Stölzle-Feix
[1:00 PM CEST]

Yasunari Kanda
PhD, Division head, National Institute of Health Sciences, Japan
Title: Current status and future perspectives in cardiac safety assessment using human iPSC technology
[1:10 PM - 2 PM CEST]

Ralf Kettenhofen
Senior Scientist and Business Development, Fraunhofer Institute for Biomedical Engineering IBMT
Title: From iPSC Banking to Drug Development & Cardiac Safety 
[2 PM - 2:30 PM CEST]

[2:30 PM - 2:45 PM CEST]

View the full program here

Register for the two-day event here

Back to Overview


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.